These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4878453)

  • 1. [The effect of pentetrazole on serum cholesterol level and on behavior of patients with cerebral arteriosclerosis].
    Merkus JW
    Ned Tijdschr Geneeskd; 1968 Sep; 112(37):1634-8. PubMed ID: 4878453
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vasoactive combination treatment in cerebrovascular sclerosis].
    Klein K
    Wien Med Wochenschr; 1973 Jan; 123(1):14-8. PubMed ID: 4405190
    [No Abstract]   [Full Text] [Related]  

  • 3. Double-blind trial of naftidrofuryl in the treatment of cerebral arteriosclerosis.
    Gerin J
    Br J Clin Pract; 1974 May; 28(5):177-8. PubMed ID: 4604345
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of Cinnarizine in cerebral arteriosclerosis. Improvement of the clinical picture as a result of increased oxygen supply and utilization due to Cinnarizine].
    Reimann-Hunziker R; Reimann-Hunziker GJ
    Praxis; 1969 Sep; 58(39):1239-42. PubMed ID: 4899503
    [No Abstract]   [Full Text] [Related]  

  • 5. Manifestations of cerebral arteriosclerosis unaffected by a vasodilator.
    Practitioner; 1969 Nov; 203(217):695-8. PubMed ID: 4391604
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term anticoagulant therapy in patients with cerebral infarction. A crontrolled clinical study.
    Enger E; Boyesen S
    Acta Med Scand Suppl; 1965; 438():1-61. PubMed ID: 5323519
    [No Abstract]   [Full Text] [Related]  

  • 7. [Psychotropic effects of a cerebral blood circulation stimulating agent in geriatric patients].
    Scholing WE; Kleiter G; Krysl LR; Riedl J
    Med Klin; 1972 Mar; 67(9):298-303. PubMed ID: 4558188
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of redergam on the cerebral circulation of patients who have suffered insults].
    Khadzhiev D
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(1):33-7. PubMed ID: 4976423
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of the cerebral manifestations of arteriosclerosis with cyclandelate.
    Young J; Hall P; Blakemore C
    Br J Psychiatry; 1974 Feb; 124(579):177-80. PubMed ID: 4596673
    [No Abstract]   [Full Text] [Related]  

  • 10. Proceedings: Comparison of the effects of dexamphetamine and 1-benzylpiperazine in former addicts.
    Campbell H; Cline W; Evans M; Lloyd J; Peck AW
    Br J Pharmacol; 1972 Feb; 44(2):369P-370P. PubMed ID: 4588221
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of pyridoxylate in patients with severe cerebral arteriosclerosis (results of a double blind trial)].
    Cottin S; Prost A; Lefevre M; Auvinet B
    Sem Hop Ther; 1974 Jan; 50(1):41-4. PubMed ID: 4603511
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of unithiol, its combination with polyvitamin preparations and cetamiphen in the treatment of patients with cerebral atherosclerosis].
    Kurliandchikov VN
    Vrach Delo; 1972 Sep; 9():24-8. PubMed ID: 4658109
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic correction of senile behavior characteristics with Wallerox. Contribution on experimental psychological geriatrics].
    Oswald WD; Müller-Egloff P; Becker E; Wilde M
    Munch Med Wochenschr; 1969 Jun; 111(26):1444-8. PubMed ID: 4980146
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical research on the aged concerning the anti-sclerotic effect of a new heparinoid extract: glycuronoglucosaminoglycan sulfate (3GS)].
    Turpini R; Caliandro L; Cocchi A; Volpi F; Brusaioli G; Grignani G; Antognetti R
    Clin Ter; 1975 May; 73(3):213-36. PubMed ID: 123842
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy of cerebral insufficiency].
    Grill P; Broicher H
    Dtsch Med Wochenschr; 1969 Nov; 94(47):2429-35. PubMed ID: 4981669
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical experiences with hexobendine in coronary disease].
    Eral N
    Arzneimittelforschung; 1968 Aug; 18(8):1094-103. PubMed ID: 5755844
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapeutic results with the cerebral vasodilator agent Instenon].
    Salomon K
    Wien Klin Wochenschr; 1967 Jun; 79(26):546-8. PubMed ID: 5585427
    [No Abstract]   [Full Text] [Related]  

  • 18. [Aescin (=Reparil) in cerebral circulation disorders. Clinical and ophthalmodynamographic observations].
    Tzavellas O; Finke J
    Wien Klin Wochenschr; 1970 Oct; 82(41):714-6. PubMed ID: 5529668
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experimental and clinical studies on the effect of Trimanyl on lipid metabolism. II. The effect of a single dose of the preparation on the level of total cholesterol and its fractions in the blood serum].
    Janicki K; Szczeciakowska L; Gurda M
    Przegl Lek; 1968; 24(12):874-7. PubMed ID: 5704541
    [No Abstract]   [Full Text] [Related]  

  • 20. [Action of pyrithioxine combined with a vasodilator in patients with cerebral arteriosclerosis].
    Schlesinger P
    Rev Bras Med; 1972 Jan; 29(1):38-41. PubMed ID: 4552863
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.